Regencell Bioscience
2 hedge funds and large institutions have $100K invested in Regencell Bioscience in 2024 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
5,209% more capital invested
Capital invested by funds: $1.89K → $100K (+$98.5K)
5.13% more ownership
Funds ownership: 0.16% → 5.29% (+5.1%)
33% less funds holding
Funds holding: 3 → 2 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$127K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$44 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $99.1K | +$127K | +667,432 | +5,629% |
|
2
BlackRock
New York
| $1.32K | – | – | – |
|
|
3
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$44 | -494 | Closed |
|
RGC Hedge Fund Activity: Q3 2024 in Review
2 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Regencell Bioscience (RGC) for Q3 2024, worth a combined $100K — up 5,209% from $1.89K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of RGC and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $127K. The largest seller was Qube Research & Technologies (QRT), exiting entirely with an estimated $44 sold.
- 2 institutional investors held Regencell Bioscience (RGC) as of Q3 2024, down from 3 in Q2 2024.
- Funds reported $100K of Regencell Bioscience stock for Q3 2024, up 5,209% quarter-over-quarter.
- 0 funds opened new Regencell Bioscience positions in Q3 2024 and 1 closed out, a net change of -1 holder.
- The largest Regencell Bioscience buyer in Q3 2024 was UBS Group, an estimated $127K added.
- The largest Regencell Bioscience seller in Q3 2024 was Qube Research & Technologies (QRT), an estimated $44 sold.
Based on aggregated 13F filings for Q3 2024.